The 3rd International Online Conference on Cells
Charming Micro-Insights into Health and Diseases
Thank you for attending Cells 2025!
On behalf of the conference organizing committee of the 3rd International Online Conference on Cells (Cells2025), we would like to express our appreciation to all the participants for their contributions!
The Cells 2025 Best Oral Presentation Awards and Best Poster Awards have been announced! Check them HERE.
Click HERE for the Certificate of Participation.
Click HERE for the Book of Abstracts.
Click HERE for the Poster Gallery.
Publication opportunities for Cells 2025 participants can be found here.
For any inquiries, please contact us at cells2025@mdpi.com.
the chair
On behalf of Cells (ISSN: 2073-4409; IF: 5.2) I welcome you to our 2025 Virtual Conference. As with our previous 2 conferences of this series, we want to provide a highly interactive platforum for researchers all over the world to discuss major achievements as well as challenges in cell biology. Our goal is to cover a wide range of topics and to get feedback from seasoned researchers and from young investigators. Cells is a very dynamic journal with its eyes and ears always open to discoveries and novel emerging directions in cell biology. The goal of our 2025 Virtual Conference is to facilitate interaction between participants and to further advance the highly collaborative spirit of cell biology science. By covering such topics as cellular pathology of cancers, neural cell biology, cellular antivirus immune responses, cell therapies, cellular signaling, cell research in animal models, cellular metabolism, protein quality control, proteasomal degradation and autophagy, Cells remains at the forefront of scientific discourse. Over time, Cells has gained a reputation as a solid scientific journal, due to its unbiased peer-review process and great attention to every submitted paper.
We are privileged to host the 3rd Online Conference and are looking forward to oral presentations which shed light on complex mechanisms underlying cellular physiology and suggest novel treatment strategies for a wide spectrum of life-threatening pathologies.
Let us exchange provocative ideas, meet collaborators and enjoy the world of science with its incredible surprises and discoveries.
Download the conference flyer and share it with your colleagues!
Dental Basic Sciences, UMN Twin Cities, Minneapolis, MN, USA
Important Dates
- Abstract submission deadlineJan 19, 2025
- Abstract acceptance notificationFeb 14, 2025
- Registration end dateMar 20, 2025
- Early bird registration deadlineFeb 18, 2025
- Regular registration deadlineMar 20, 2025
Meet Our Speakers
Prof. Dr. Illana Gozes
The Elton Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Faculty of Medical and Health Sciences, School of Medicine, The Adams Super Center for Brain Studies and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel;
Professor Emerita Tel Aviv University (TAU), formerly Lily and Avraham Gildor Chair and Director of the Adams Super Center for Brain Studies. Currently, Director, Elton Laboratory for Molecular Neuroendocrinology. B.Sc. TAU, Ph.D., Weizmann Institute of Science, postdoc. MIT and Salk Institute. Associate Professor, Weizmann Institute, Fogarty-Scholar-in-Residence, NIH, Humboldt Awardee, Germany. Mentored >80 students. Published ~400 papers (h-index 85 -Google Scholar). Inventor of multiple patents including (NAP, Davunetide), a clinical drug candidate targeted at the rare disease indication, the ADNP syndrome and beyond. Discovered ADNP, essential for brain formation implicated in autism, schizophrenia, Alzheimer’s disease and cancer. NAP is the active site of ADNP. Multiple prizes including Teva Founders Prize, Landau Prizes and best applied scientist, TAU. Ex-President, Israel Society for Neuroscience (Honorary Member), Ex-Member, Council of Higher Education. President, European Society for Neurochemistry. Editor-in-Chief, Journal of Molecular Neuroscience, Vice President, Research and Development, ExoNavis Therapeutics.
Prof. Maurizio Molinari
Protein Folding and Quality Control, Institute for Research in Biomedicine (IRB), CH-6500 Bellinzona, Switzerland;
The research group of Maurizio Molinari at the IRB in Bellinzona aims at the characterization of molecular mechanisms that control size, activity and homeostasis of the ER, the major biosynthetic organelle of nucleated cells. The group identified SEC62 as the ER-phagy receptor activated during recovery from ER stress to remove excess portions of the ER and of the outer nuclear membrane to re-establish the physiologic ER and nuclear envelope ultrastructure and activity. The group also reported the first example of ER-phagy receptor (FAM134B)-mediated clearance of ER portions containing terminally misfolded polypeptides, named these catabolic processes ER-to-Lysosome-Associated Degradation (ERLAD), and showed that ERLAD acts in concert with ER-associated degradation (ERAD), which relies on the intervention on the ubiquitin/proteasome system, to efficiently remove from cells toxic and aberrant gene products.
Dr. Bilal Hafeez
Department of Immunology and Microbiology, South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA;
Dr. Hafeez is an Assistant Professor in the department of Medicine and Oncology at the University of Texas Rio Grande Valley School of Medicine and has a broad background in cancer biology, molecular therapeutics, and molecular biology with specific expertise in generating various pre-clinical mouse models of solid tumors. He has also generated various mouse models (orthotopic, xenograft, conditional Pten-knockout and transgenic) of prostate cancer. Currently, his lab research is dedicated to understanding the molecular mechanisms of ribosome biogenesis dysregulation in solid tumors and how targeting ribosome biogenesis by RNA polymerase inhibitor can suppress the growth of advanced pancreatic cancer. Dr. Hafeez serves both PI and Co-I on multiple NIH-funded grants and has published more than 60 high-impact cancer research articles in peer-reviewed journals.
Prof. Ewa Zuba-Surma
Department of Cell Biology, Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University, Krakow, Poland;
Prof. Ewa Zuba-Surma is a Group Leader in Department of Cell Biology at the Faculty of Biochemistry, Biophysics and Biotechnlogy at the Jagiellonian University in Krakow.
Her research interest is related to mechanisms of action and applications of selected stem cell populations and their derivatives (extracellular vesicles, EVs) in tissue regeneration, especially in ischemic tissue repair and orthopedic injuries. Prof. E. Zuba-Surma conducts translational resarch ficused on stem cell and EV aplications in medicine including pre-clinical and clinical studies with patients. She is also an expert in novel flow cytometric platforms including imaging and high resolution cytometry, which she uses with her team for identification and characterization of several stem cell populations and their derivatives.
Prof. E. Zuba-Surma is an author of more than 150 publications in stem cell and regenerative medicine fields and co-authors of 10 patent and patent applications in stem cell area. She was awarded with several national and international prices for scientific achievements and she is actively founded by several grant agencies (NCN, NCBiR, FNP).
Prof. Philippa Mills
Inborn Errors of Metabolism, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK;
Prof. Philippa Mills received her Ph.D. in Biochemistry from Cardiff University in 1995. She continued her scientific career as a Postdoctoral Scientist at the Royal Holloway University of London, and subsequently at UCL Great Ormond Street Institute of Child Health (GOS ICH), London as a Senior Post-Doctoral fellow in the Mass Spectrometry Unit at the Institute of Child Health, UCL in 1999. Here she began working in the field of inherited metabolic diseases and in 2006 was awarded the Horst-Bickel prize for important pioneering research into inborn errors of vitamin B6 metabolism. In 2010 she was awarded an NIHR Biomedical Research Centre Fellowship shortly before she was appointed as a Lecturer in Metabolic Paediatrics at UCL Institute of Child Health. She was promoted to the positon of Associate Professor in 2017 and more recently to Professor in 2021. Her research focuses on improving the diagnosis and treatment of children with inherited metabolic disorders, primarily those that cause neurological disease including the vitamin B6-dependent epilepsies.
Prof. Dr. Natália Cruz-Martins
Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal, Faculty of Medicine, University of Porto, Porto, Portugal;
Natália Cruz-Martins is Researcher at the Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal, and Visiting Professor at the Faculty of Medicine, University of Porto, Portugal. Her areas of expertise are nutrition, phytochemistry and phytopharmacology, biochemistry, microbiology, drug discovery, functional foods, nutraceuticals, infectious diseases and public health. Since 2017, she has been a university lecturer, supervising theses and participating in various research projects, in recent years mostly of a clinical nature. With more than 300 published articles (H-index of 76), 2 edited books and several book chapters, she is also a reviewer and editorial member of several indexed journals and an international reviewer of scientific funding proposals. She is a member of CONEM (Norway) and Global Burden of Diseases (USA) network.
DAY 1
Session A. Cellular Pathology of Cancers
Session D. Cell Therapies
Session C. Cellular Antivirus Immune Responses
DAY 2
Session E. Cellular Signaling &
Session F. Cell Research in Animal Models
DAY 3
Session H. Protein Quality Control, Proteasomal Degradation, and Autophagy &
Flash Poster Session
Session G. Cellular Metabolism & Session B. Neural Cell Biology
Ms. Dorothy Cai
Ms. Katrina Zhang